Fundraising Fox

Doug Kerr

Investor

Science Advisor at Exceptional Ventures

Boston/Cambridge

Writes $100K – $5M checks · typically $1.5M

Find your path to Doug

316 people in our graph share verified history with Doug — schools, employers, funds. One of them is your warm intro.

David CoatsunlockedDoug: together at Princeton University (1984–1987)
Doug: together at Princeton University
Doug: together at Northeastern University
×3Doug: together at Atlas Venture

About

Science Advisor and Chief Medical Officer at Generation Bio, a gene therapy company he co-founded. Holds an MD and PhD, was a professor at Johns Hopkins, and led development of the SMA therapy Spinraza.

Experience

  1. Dyne TherapeuticsChief Medical Officercurrent2024 — presentWaltham, Massachusetts, United States
  2. Trace NeurosciencesMember, Board and SABcurrent2024 — presentSan Francisco Bay Area
  3. BlueRock TherapeuticsBoard Membercurrent2023 — presentCambridge, Massachusetts, United States
  4. GenRab TherapeuticsBoard Membercurrent2022 — presentDallas, Texas, United States
  5. Exceptional VenturesAdvisor and LPcurrent2022 — presentGreater London, England, United Kingdom
  6. Siegel Rare Neuroimmune AssociationMember, Board and SABcurrent2009 — presentColumbus, Ohio Metropolitan Area
  7. Atlas VentureVenture Partner2024 — 2025Cambridge, Massachusetts, United States
  8. AAVantgarde BioBoard Member2023 — 2025Milan, Lombardy, Italy
  9. Generation BioChief Medical Officer2020 — 2024Cambridge, Massachusetts, United States
  10. Generation BioChief Development Officer2019 — 2020Cambridge, Massachusetts, United States
  11. Generation BioEVP, Head of Preclinical Research & Clinical Development2018 — 2019Cambridge MA
  12. Generation BioEVP Head of R & D, Chief Scientific Officer2017 — 2018Cambridge MA
  13. Faze MedicinesBoard Member, Chair Compensation Committee2021 — 2023Cambridge MA
  14. Triplet TherapeuticsBoard Member2019 — 2023Cambridge, Massachusetts
  15. Disarm TherapeuticsMember, Scientific Advisory Board2018 — 2020Cambridge, Massachusetts
  16. CureSMABoard of Directors, Chair Science and Medicine Committee2018 — 2020Illinois
  17. ShireGlobal VP Neurology Development Lead2015 — 2017Lexington MA
  18. BiogenSenior Director, Corporate Strategy and Portfolio Management2014 — 2015
  19. BiogenSenior Medical Director Research and Development, Neurodegeneration2013 — 2015
  20. BiogenSenior Medical Director2013 — 2014
  21. Biogen IdecDirector, Neurology Research and Development2010 — 2013
  22. BiogenAssociate Director, Experimental Neurology2008 — 2010
  23. Johns Hopkins School of MedicineAssociate Professor1999 — 2008

Skills & more

Molecular Biology8Neurology33Clinical Development6Drug Development27Lifesciences7Neuroscience11Immunology7Clinical Trials34Biochemistry5Spine1Biotechnology21Genetics3
+12 morePharmaceutical IndustryCell BiologyBioinformaticsLife SciencesDrug DiscoveryMedicinePharmacologyCancerClinical ResearchStem CellsInfectious DiseasesCell Culture

From Doug's professional profile.

Colleagues at Exceptional Ventures

Alex Laterza
Advisor at Exceptional Ventures
Alex Söderman
CFO & Compliance Officer at Exceptional Ventures
Federica Pio
Scout at Exceptional Ventures
Federico Raoul Cucchi
Partner at Exceptional Ventures
Frederica Dick-Read
Executive Assistant at Exceptional Ventures
Jason Foster
Scout at Exceptional Ventures
Joan Miquel Marcos Salleras
Visiting Analyst at Exceptional Ventures
Mark Schilling
Head of Capital Formation at Exceptional Ventures

Network4

Alex Laterza
Advisor at Exceptional Ventures
Alex Söderman
CFO & Compliance Officer at Exceptional Ventures
Federico Raoul Cucchi
Partner at Exceptional Ventures
Raj Singh
Investor at Exceptional Ventures

Investors connected to Doug in public investor directories — a warm-intro map.

Frequently asked questions

Who is Doug Kerr?
Science Advisor and Chief Medical Officer at Generation Bio, a gene therapy company he co-founded. Holds an MD and PhD, was a professor at Johns Hopkins, and led development of the SMA therapy Spinraza.
Where does Doug Kerr work?
Doug Kerr is Science Advisor at Exceptional Ventures.
What check size does Doug Kerr write?
Doug Kerr typically writes checks of $100K – $5M.
Where did Doug Kerr go to school?
Doug Kerr studied at Princeton University (BA, Biology); Northeastern University (Master of Business Administration (MBA), Business Administration and Management); The Johns Hopkins University School of Medicine (Neurology Residency Program).

Same school

Also attended Princeton University877

Fabrice GrindaCo-founder & Managing Partner at FJ LabsRyan SheaCo-founder of Blockstack (Stacks)Dario AmodeiCo-founder & CEO of AnthropicFei-Fei LiCo-founder & CEO of World Labs; Sequoia Professor of Computer Science at StanfordCat WuInvestor at Index VenturesAndrewAdvisor at Clear Ventures

+ 871 more

Also attended Northeastern University380

Matt GuineyChief Financial Officer at Flybridge Capital PartnersAllison KuziwGlobal Human Resources Executive at Marlin Equity PartnersSaunaz MoradiPartner, Communications at Lux CapitalBrian DixonManaging Partner at Kapor CapitalMurat BicerGeneral Partner at CRV (Charles River Ventures)Christopher WolfChief Financial Officer at MPM BioImpact

+ 374 more

Also attended The Johns Hopkins University School of Medicine59

Hal PazInvestor at Khosla VenturesRochelle WalenskyExecutive Partner at Flare Capital PartnersBeth SeidenbergFounding Managing Director at Westlake Village BioPartnersStephen P. ZacharyManaging Partner at Sands Capital VenturesS.K. LeeExecutive Coach at Roble VenturesEric HsuAnalyst, Private Equity at Sofinnova Ventures

+ 53 more

Also attended Jefferson Health8

Kevin ZhangVenture Partner at Bain Capital CryptoArlen MeyersAdvisory Board at InVitro CapitalDr. Justin YoungVenture Partner at Boutique Venture PartnersMayank TanejaVice President, Venture Investments at OSF VenturesRobert DrakasPresident at ShangPharma InnovationCaitlin SwiftFounder at Clara

+ 2 more

Shared employers

Also worked at Dyne Therapeutics6

Carlo IncertiOperating Partner at ForbionJason RhodesPartner at Atlas VentureSudhir AgrawalInvestor at 82VSRomesh SubramanianVenture Partner at Scion Life SciencesPhillip SamayoaPrincipal at Atlas VentureStephen CurtisManaging Partner at MPM BioImpact

Also worked at BlueRock Therapeutics2

Jerel DavisManaging Director at Versant VenturesGraham WalmsleyGeneral Partner at Logos

Also worked at Atlas Venture64

Karim FarisInvestor at GV (Google Ventures)Nessan BerminghamInvestor at Khosla VenturesKristen LaguerreExecutive Partner at MPM BioImpactJeanne HenryCFO at Excel Venture ManagementGretchen McCareyChief Financial Officer at Castle Island VenturesKate GunioController at Long Ridge Equity Partners

+ 58 more

Also worked at Generation Bio2

Jeffrey M. JonasPartner at Cure VenturesPhillip SamayoaPrincipal at Atlas Venture